We align purpose and profit by creating a model where marketplace success fuels meaningful mission and meaningful mission strengthens marketplace success. Together they create lasting solutions that expand hope, improve wellness, and sustain long-term impact. This is the Buy One, Nourish One model that we call Social Business 3.0.
We champion solution-oriented products that are scientifically developed and intentionally formulated to support meaningful physiological outcomes. By combining research-driven innovation with proprietary technologies and exclusive distribution relationships, we provide products designed to create measurable value for both consumers and the mission we serve.
Through our innovative Social Business 3.0 model, everyday purchasing becomes something bigger than a transaction—it becomes a compelling source of hope. Every purchase contributes to extending nutrition and support to vulnerable children around the world, and we measure success by the impact we create together. We call it the Hope Movement.
When we think about the quality of a health care system, it is tempting to begin with the sophistication of its hospitals, the expertise of its physicians, or the extraordinary medical technologies now available. And Read more
Sam Caster has long been drawn to disruptive innovation—not simply creating better products, but rethinking entire business models. Just as he sought technologies capable of disrupting established industries, he recognized that the traditional direct sales Read more
Alovéa: Built for the Long Term, Not the Short Term When members of the Alovéa field hear directly from company leadership, they naturally want answers to a few important questions: During a recent business discussion, Read more
How Aloe Gel and Its Acemannan-Rich Polysaccharides May Help Nutrients Reach Their Destination Click Play to begin Let’s begin with a question that almost nobody asks. When you swallow a nutritional supplement…what has to happen Read more
What a preliminary study suggests about Acemannan-based nutrition and learning-disabled children Click Play to begin Today we are going to uncover the data behind what is called a preliminary investigation. This will be another dive Read more
What the Data Reveal About First-Generation Acemannan and Early Symptom ImprovementClick the Play button to begin Today we’re going to examine a small but fascinating pilot study published in 1998. The researchers set out to Read more
Tony McWilliams
469-955-2001
Or contact the person who told you about this site